Log In
Print
BCIQ
Print
Print this Print this
 

ND0612L

Also known as: ND0612

  Manage Alerts
Collapse Summary General Information
Company NeuroDerm Ltd.
DescriptionLow-dose formulation of liquid levodopa and carbidopa delivered via a continuous, subcutaneous belt pump
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationParkinson's disease (PD)
Indication DetailsTreat moderate Parkinson's disease (PD); Treat moderate to severe Parkinson's disease (PD)
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today